Low-molecular-weight heparin improves the performance of uterine artery Doppler velocimetry to predict preeclampsia and small-for-gestational age infant in women with gestational hypertension

Ultrasound in Medicine and Biology

Volumn 32, Issue 9, 2006, Pages 1431-1435

  Torricelli, Michela ^a   Reis, Fernando M ^b   Florio, Pasquale ^a   Severi, Filiberto M ^a   Bocchi, Caterina ^a   Picciolini, Enrico ^a   Guidoni, Claudio G ^a   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Doppler; Fetal growth restriction; Gestational hypertension; Heparin; Preeclampsia

Indexed keywords

FETAL GROWTH RESTRICTION; GESTATIONAL HYPERTENSION; HEPARIN; PREECLAMPSIA;

DOPPLER EFFECT; HEALTH CARE; MOLECULAR WEIGHT; PATIENT TREATMENT; ULTRASONICS; VELOCITY MEASUREMENT;

POLYSACCHARIDES;

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTERY RESISTANCE; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; GESTATIONAL AGE; HIGH RISK POPULATION; HIGH RISK PREGNANCY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; SMALL FOR DATE INFANT; TREATMENT OUTCOME; UTERINE ARTERY; UTERUS BLOOD FLOW;

ADULT; ANTICOAGULANTS; ARTERIES; FEMALE; FETAL GROWTH RETARDATION; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROGNOSIS; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; UTERUS; VASCULAR RESISTANCE;

EID: 33748313018     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2006.05.030     Document Type: Article

References (20)

1. Albaiges G., Missfelder-Lobos H., Lees C., Parra M., and Nicolaides K.H. One-stage screening for pregnancy complications by colour Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 96 (2000) 559-564
2. Bird I.M., Zhang L., and Magness R.R. Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function. Am J Physiol Regul Integr Comp Physio 284 (2003) R245-R258
3. Buzun L., Kleszczewski T., Kostrzewska A., et al. Influence of low molecular weight heparin preparations on human internal thoracic artery contraction. Eur J Cardiothorac Surg 26 (2004) 951-955
4. D'Aniello G., Florio P., Sabatini L., et al. The search for thrombophilic gene mutations in women with gestational hypertension does not help in predicting poor pregnancy outcome. J Hypertens 21 (2003) 1915-1920
5. Di Simone N., Caliandro D., Castellani R., et al. Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod 14 (1999) 489-495
6. Duley L., Henderson-Smart D., Knight M., and King J. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ 322 (2001) 329-333
7. Greenberg S.G., Baker R.S., Yang D., and Clark K.E. Effects of continuous infusion of endothelin-1 in pregnant sheep. Hypertension 30 (1997) 1585-1590
8. Greiss Jr. F.C. Pressure-flow relationship in the gravid uterine vascular bed. Am J Obstet Gynecol 96 (1996) 46-47
9. Khan K.S., Khan S.F., Nwosu C.R., Arnott N., and Chien P.F. Misleading authors' inferences in obstetric diagnostic test literature. Am J Obstet Gynecol 181 (1999) 112-115
10. Manduteanu I., Voinea M., Capraru M., Dragomir E., and Simionescu M. A novel attribute of enoxaparin: inhibition of monocyte adhesion to endothelial cells by a mechanism involving cell adhesion molecules. Pharmacology 65 (2002) 32-37
11. Mello G., Parretti E., Fatini C., et al. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 45 (2005) 86-91
12. Poston L., McCarthy A.L., and Ritter J.M. Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol Ther 65 (1995) 215-239
13. Quenby S., Mountfield S., Cartwright J.E., Whitley G.S., and Vince G. Effects of low-molecular-weight and unfractionated heparin on trophoblast function. Obstet Gynecol 104 (2004) 354-361
14. Reantragoon S., Arrigo L.M., Seoud M.M., Dweck H.S., and Rosenfeld L. Specific heparin fractions suppress endothelin-1 production in cultured human umbilical vein endothelial cells. Arch Biochem Biophys 314 (1994) 315-322
15. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 183 (2000) S1-S22
16. Roberts J.M., and Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 357 (2001) 53-56
17. Sibai B.M. Hypertension in pregnancy. In: Gabbe S.G., Niebyl J.R., and Simpson J.L. (Eds). Obstetrics: normal and problem pregnancies (1996), Churchill Livingstone, New York 935-996
18. Tangphao O., Chalon S., Moreno Jr. H.J., et al. Heparin-induced vasodilation in human hand veins. Clin Pharmacol Ther 66 (1999) 232-238
19. Tasatargil A., Ogutman C., Golbasi I., Karasu E., and Dalaklioglu S. Comparison of the vasodilatory effect of nadroparin, enoxaparin, dalteparin, and unfractioned heparin in human internal mammary artery. J Cardiovasc Pharmacol 45 (2005) 550-554
20. Yudkin P.L., Aboualfa M., Eyre J.A., Redman C.W., and Wilkinson A.R. New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. Early Hum Dev 15 (1987) 45-52